Mark Pinese

Citata da

	Tutte	Dal 2020
Citazioni	17316	11063
Indice H	42	34
i10-index	54	50

2600

1300

650

1950

20112012201320142015201620172018201920202021202220232024202559 98 249 355 522 876 1114 1325 1467 1932 2519 2326 1954 1921 408

Accesso pubblico

Visualizza tutto

50 articoli

3 articoli

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Andrew BiankinRegius Professor of Surgery, University of GlasgowEmail verificata su glasgow.ac.uk
David K. ChangProfessor of Surgical Oncology, University of GlasgowEmail verificata su glasgow.ac.uk
James KenchLocal Pathology Director, Royal Prince Alfred Hospital and Clinical Professor, University of SydneyEmail verificata su health.nsw.gov.au
Nicola WaddellQIMR Berghofer Medical Research InstituteEmail verificata su qimrberghofer.edu.au
Anthony GillProfessor of Surgical Pathology, University of SydneyEmail verificata su med.usyd.edu.au
Adnan NagrialUniversity of SydneyEmail verificata su health.nsw.gov.au
Sandra O'TooleClinical Professor Sydney University and Staff Specialist Tissue Pathology Royal Prince Alfred HospitalEmail verificata su garvan.org.au
john v pearsonQIMR Berghofer MRIEmail verificata su qimrberghofer.edu.au
Chelsea MayohChildren's Cancer Institute, Sydney, AustraliaEmail verificata su ccia.org.au
Velimir GayevskiyRancho BiosciencesEmail verificata su vel.bio
Marie WongChildren's Cancer InstituteEmail verificata su ccia.org.au
Marcel E. DingerUniversity of SydneyEmail verificata su marceldinger.net
David S ZieglerSydney Children's HospitalEmail verificata su unsw.edu.au
Prof. Sean M. GrimmondCollaborative Centre for Genomic Cancer Medicine, University of MelbourneEmail verificata su unimelb.edu.au
Venessa ChinGarvan Institute of Medical ResearchEmail verificata su garvan.org.au
lorraine chantrillSenior Staff Specialist and Director Medical Oncology; Illawarra Shoalhaven Local Health DistrictEmail verificata su health.nsw.gov.au
Angela ChouRoyal North Shore Hospital and Kolling Institute of Medical ResearchEmail verificata su sydney.edu.au
Roger DalyDept of Biochemistry and Molecular Biology, Monash UniversityEmail verificata su monash.edu
Nigel B JamiesonProfessor of Surgery and Consultant HPB Surgeon, Glasgow UniversityEmail verificata su glasgow.ac.uk
CJ OrmandyFounder and Director MammBio Pty Ltd and Visiting Scientist Garvan Institute of Medical ResearchEmail verificata su garvan.org.au

Segui

Mark Pinese

Children's Cancer Institute

Email verificata su ccia.org.au

Genomics Cancer Biostatistics Bioinformatics


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
Genomic analyses identify molecular subtypes of pancreatic cancer P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ... Nature 531 (7592), 47-52, 2016	3531	2016
Whole genomes redefine the mutational landscape of pancreatic cancer N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ... Nature 518 (7540), 495-501, 2015	2809	2015
Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020	2540*	2020
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ... Nature 491 (7424), 399-405, 2012	2299	2012
Whole-genome landscape of pancreatic neuroendocrine tumours A Scarpa, DK Chang, K Nones, V Corbo, AM Patch, P Bailey, RT Lawlor, ... Nature 543 (7643), 65-71, 2017	949	2017
PINA v2. 0: mining interactome modules MJ Cowley, M Pinese, KS Kassahn, N Waddell, JV Pearson, ... Nucleic acids research 40 (D1), D862-D865, 2012	397	2012
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer M Wong, C Mayoh, LMS Lau, DA Khuong-Quang, M Pinese, A Kumar, ... Nature medicine 26 (11), 1742-1753, 2020	303	2020
Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy BW Miller, JP Morton, M Pinese, G Saturno, NB Jamieson, E McGhee, ... EMBO molecular medicine 7 (8), 1063-1076, 2015	292	2015
Genome‐wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT‐ROBO, ITGA2 and MET signaling K Nones, N Waddell, S Song, AM Patch, D Miller, A Johns, J Wu, ... International journal of cancer 135 (5), 1110-1118, 2014	265	2014
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis C Vennin, VT Chin, SC Warren, MC Lucas, D Herrmann, A Magenau, ... Science translational medicine 9 (384), eaai8504, 2017	262	2017
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan C Vennin, P Mélénec, R Rouet, M Nobis, AS Cazet, KJ Murphy, ... Nature communications 10 (1), 3637, 2019	243	2019
Hypermutation in pancreatic cancer JL Humphris, AM Patch, K Nones, PJ Bailey, AL Johns, S McKay, ... Gastroenterology 152 (1), 68-74. e2, 2017	225	2017
Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells F Hochgräfe, L Zhang, SA O'Toole, BC Browne, M Pinese, A Porta Cubas, ... Cancer research 70 (22), 9391-9401, 2010	215	2010
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater DK Chang, NB Jamieson, AL Johns, CJ Scarlett, M Pajic, A Chou, ... Journal of clinical oncology 31 (10), 1348-1356, 2013	195	2013
Clinical and molecular characterization of HER2amplified-pancreatic cancer A Chou, N Waddell, MJ Cowley, AJ Gill, DK Chang, AM Patch, K Nones, ... Genome medicine 5, 1-11, 2013	147	2013
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer A Chou, D Froio, AM Nagrial, A Parkin, KJ Murphy, VT Chin, D Wohl, ... Gut 67 (12), 2142-2155, 2018	132	2018
Targeting DNA damage response and replication stress in pancreatic cancer SB Dreyer, R Upstill-Goddard, V Paulus-Hock, C Paris, EM Lampraki, ... Gastroenterology 160 (1), 362-377. e13, 2021	129	2021
Identification of functional networks of estrogen-and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer EA Musgrove, CM Sergio, S Loi, CK Inman, LR Anderson, MC Alles, ... PloS one 3 (8), e2987, 2008	121	2008
Brief report: potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma DS Ziegler, M Wong, C Mayoh, A Kumar, M Tsoli, E Mould, V Tyrrell, ... British Journal of Cancer 119 (6), 693-696, 2018	119	2018
qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profiles S Song, K Nones, D Miller, I Harliwong, KS Kassahn, M Pinese, M Pajic, ... Public Library of Science 7 (9), e45835, 2012	119	2012

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori